---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-030997"
form_type: "8-K"
ticker: "SLS"
cik: "0001390478"
company_name: "SELLAS Life Sciences Group, Inc."
filed_at: "2024-03-05T23:59:59+00:00"
generated_at: "2026-06-05T03:34:49.048562+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# SELLAS Life Sciences regains Nasdaq compliance for minimum market value rule

## Summary
- Received Nasdaq letter on March 5, 2024 confirming compliance with Listing Rule 5550(b)(2).
- Company maintained market value of common stock above $35M for 10 consecutive business days.
- Previous non-compliance notice received on December 6, 2023; matter now closed.
- Regains compliance before the June 3, 2024 deadline.

## SEC filing metadata
- accession: 0001104659-24-030997
- form_type: 8-K
- ticker: SLS
- cik: 0001390478
- company_name: SELLAS Life Sciences Group, Inc.
- filed_at: 2024-03-05T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1390478/000110465924030997/0001104659-24-030997-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1390478/000110465924030997/tm248024d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-030997
- JSON: https://secwatch.observer/filing/0001104659-24-030997.json
- Plain text: https://secwatch.observer/filing/0001104659-24-030997.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.